Disease modifying effects of simvastatin &/or telmisartan on pulmonary function in patients with mild to moderate chronic obstructive pulmonary disease(COPD)
Background: chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
Main Authors: | Ali M. Hadi, Kasim Jaleel Al-Shamma, Qais Ali Habeeb |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Medicine University of Baghdad
2012-01-01
|
Series: | مجلة كلية الطب |
Subjects: | |
Online Access: | http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/819 |
Similar Items
-
Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
by: Sean Duffy, et al.
Published: (2017-06-01) -
Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease
by: Pabst S, et al.
Published: (2009-12-01) -
TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY
by: V. I. Podzolkov, et al.
Published: (2015-12-01) -
[Acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD)]
by: Domenico Lorenzo Urso
Published: (2017-07-01) -
Treatment of proteinuria in dogs with telmisartan: A retrospective study
by: Julie Lecavalier, et al.
Published: (2021-07-01)